Therapeutic Solutions International Universal Donor Immunotherapy StemVacs™ Activates Antiviral Immune Cells While Protecting Lungs From "Cytokine Storm" Preclinical Experiments for Upcoming FDA Submission Reveal Possible Dual Benefit in COVID-19 Model
StemVacs™ preparation involves "forcing" the dendritic cells to mature by treatment with leukocyte derived extracts, which appears to induce higher expression of immune-stimulatory molecules as compared to standard approaches.